Magnesium deficiency and oxidative stress: An update

BioMedicine (Taiwan)

Volumn 6, Issue 4, 2016, Pages 8-14

  Zheltova, Anastasia A ^a   Kharitonova, Maria V ^a,b   Iezhitsa, Igor N ^a,c   Spasov, Alexander A ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Antioxidants; Lipid peroxidation; Magnesium; Magnesium deficiency; Oxidative stress; Reactive oxygen species

Indexed keywords

DNA; LIPID; PROTEIN;

ANTIOXIDANT ACTIVITY; DISEASE ASSOCIATION; DNA MODIFICATION; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; MAGNESIUM DEFICIENCY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 84996483360     PISSN: 22118020     EISSN: 22118039     Source Type: Journal    
DOI: 10.7603/s40681-016-0020-6     Document Type: Review

References (93)

1. Park S, Johnson M, Fischer JG. Vitamin and mineral supplements: barriers and challenges for older adults. J Nutr Elder. 2008; 27: 297-317. doi: 10.1080/01639360802265855.
2. Boy E, Mannar V, Pandav C, de Benoist B, Viteri F, Fontaine O, et al. Achievements, challenges, and promising new approaches in vitamin and mineral deficiency control. Nutr Rev. 2009; 67 Suppl 1: S24-S30. doi: 10.1111/j.1753-4887.2009.00155.x.
3. Suskind DL. Nutritional deficiencies during normal growth. Pediatr Clin North Am. 2009; 56: 1035-53. doi: 10.1016/j.pcl.2009.07.004.
4. Spasov AA, Orobinskaia TA, Smirnova LA. Magnesium salts in physiology and pathology: the potentials for their use in medicine. Usp Fiziol Nauk. 1997; 28: 79-93.
5. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr. 1994; 13: 429-46.
6. Elisaf M, Merkourpoulos M, Tsianos EV, Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995 Dec; 9: 210-4.
7. Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol. 2009; 24: 697-705.
8. Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016; 65: 3-13.
9. Lima Mde L, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009; 83: 257-62.
10. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015; 95: 1-46.
11. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999; 10: 1616-22.
12. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003; 24: 47-66.
13. Pham PC, Pham PA, Pham SV, Pham PT, Pham PM, Pham PT. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis. 2014; 7: 219-30.
14. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res. 2009; 22: 235-46. doi: 10.1684/mrh.2009.0187.
15. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997; 82: 291-5.
16. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. 2004; 142: 231-55.
17. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007; 35: 1147-50.
18. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood). 2002; 227: 671-82.
19. Heistad DD. Oxidative stress and vascular disease: 2005 Duff lecture. Arterioscler Thromb Vasc Biol. 2006; 26: 689-95.
20. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107: 1058-70.
21. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008; 295: C849-C868. doi: 10.1152/ajpcell.00283.2008.
22. Zaitsev VG, Ostrovskii OV. Markers of oxidative lesion and antioxidative system for the use in clinical laboratory diagnosis. Klin Lab Diagn. 2008; 9: 61.
23. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995; 41: 1819-28.
24. Lee SH, Blair IA. Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med. 2001; 11: 148-55.
25. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006; 52: 601-23.
26. Ryzen E, Elbaum N, Singer FR, Rude RK. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium. 1985; 4: 137-47.
27. Elin RJ. Magnesium metabolism in health and disease. Dis Mon. 1988; 34: 161-218.
28. Wegner M, Araszkiewicz A, Zozulinska-Ziólkiewicz D, Wierusz-Wysocka B, Piorunska-Mikolajczak A, Piorunska-Stolzmann M. The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes. Magnes Res. 2010; 23: 97-104. doi: 10.1684/mrh.2010.0207.
29. Mahabir S, Wei Q, Barrera SL, Dong YQ, Etzel CJ, Spitz MR, Forman MR. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008; 29: 949-56. doi: 10.1093/carcin/bgn043.
30. Hartwig A. Role of magnesium in genomic stability. Mutat Res. 2001; 475: 113-1121.
31. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of glutathione on red blood cell intracellular magnesium: relation to glucose metabolism. Hypertension. 1999; 34: 76-82.
32. Cernak I, Savic V, Kotur J, Prokic V, Kuljic B, Grbovic D, et al. Alterations in magnesium and oxidative status during chronic emotional stress. Magnes Res. 2000; 13: 29-36.
33. Bae YJ, Choi MK. Magnesium intake and its relevance with antioxidant capacity in Korean adults. Biol Trace Elem Res. 2011; 143: 213-25. doi: 10.1007/s12011-010-8883-y.
34. Gueux E, Azais-Braesco V, Bussière L, Grolier P, Mazur A, Rayssiguier Y. Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. Br J Nutr. 1995; 74: 849-56.
35. Mak IT, Komarov AM, Wagner TL, Stafford RE, Dickens BF, Weglicki WB. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am J Physiol. 1996; 271: C385-C390.
36. Wolf FI, Trapani V, Simonacci M, Boninsegna A, Mazur A, Maier JA. Magnesium deficiency affects mammary epithelial cell proliferation: involvement of oxidative stress. Nutr Cancer. 2009; 61: 131-6. doi: 10.1080/01635580802376360.
37. Hans CP, Chaudhary DP, Bansal DD. Magnesium deficiency increases oxidative stress in rats. Indian J Exp Biol. 2002; 40: 1275-9.
38. Blache D, Devaux S, Joubert O, Loreau N, Schneider M, Durand P, et al. Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats. Free Radic Biol Med. 2006; 41: 277-84.
39. Shivakumar K, Kumar BP. Magnesium deficiency enhances oxidative stress and collagen synthesis in vivo in the aorta of rats. Int J Biochem Cell Biol. 1997; 29: 1273-8.
40. Kuzniar A, Mitura P, Kurys P, Szymonik-Lesiuk S, Florianczyk B, Stryjecka-Zimmer M. The influence of hypomagnesemia on erythrocyte antioxidant enzyme defence system in mice. Biometals. 2003; 16: 349-57.
41. Boparai RK, Kiran R, Bansal DD. Insinuation of exacerbated oxidative stress in sucrose-fed rats with a low dietary intake of magnesium: evidence of oxidative damage to proteins. Free Radic Res. 2007; 41: 981-9.
42. Zeller W, Weber H, Panoussis B, Bürge T, Bergmann R. Refinement of blood sampling from the sublingual vein of rats. Lab Anim. 1998; 32: 369-76.
43. Iezhitsa IN, Spasov AA, Kharitonova MV, Kravchenko MS. Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan. Nutr Neurosci. 2011; 14: 10-24. doi: 10.1179/174313211X12966635733 277.
44. Hawkins CL, Morgan PE, Davies MJ. Quantification of protein modification by oxidants. Free Radic Biol Med. 2009; 46: 965-88. doi: 10.1016/j.freeradbiomed.2009.01.007.
45. thMeeting of the Asia Pacific Federation of Pharmacologists, 9-13 July, 2013, Shanghai, China, Acta Pharmacol Sin. 2013, 34 (Supplement), 151-151 (S13. 19).
46. Martin H, Richert L, Berthelot A. Magnesium deficiency induces apoptosis in primary cultures of rat hepatocytes. J Nutr. 2003; 133: 2505-11.
47. Martin H, Abadie C, Heyd B, Mantion G, Richert L, Berthelot A. N-acetylcysteine partially reverses oxidative stress and apoptosis exacerbated by Mg-deficiency culturing conditions in primary cultures of rat and human hepatocytes. J Am Coll Nutr. 2006; 25: 363-9.
48. Wolf FI, Trapani V, Simonacci M, Ferré S, Maier JA. Magnesium deficiency and endothelial dysfunction: is oxidative stress involved? Magnes Res. 2008; 21: 58-64.
49. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett. 1992; 311: 187-91.
50. Joborn H, Akerström G, Ljunghall S. Effects of exogenous catecholamines and exercise on plasma magnesium concentrations. Clin Endocrinol (Oxf). 1985; 23: 219-26.
51. Rayssiguier Y, Libako P, Nowacki W, Rock E. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation. Magnes Res. 2010; 23: 73-80. doi: 10.1684/mrh.2010.0208.
52. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2007; 458: 48-56.
53. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res. 2009; 22: 57-9.
54. Libako P, Nowacki W, Rock E, Rayssiguier Y, Mazur A. Phagocyte priming by low magnesium status: input to the enhanced inflammatory and oxidative stress responses. Magnes Res. 2010; 23: 1-4. doi: 10.1684/mrh.2009.0201.
55. Bussière FI, Gueux E, Rock E, Mazur A, Rayssiguier Y. Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr. 2002; 41: 197-202.
56. Butterfield TA, Best TM, Merrick MA. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train. 2006; 41: 457-65.
57. Spasov AA, Iezhitsa IN, Kravchenko MS, Kharitonova MV. Study of anti-inflammatory activity of some organic and inorganic magnesium salts in rats fed with magnesium-deficient diet. Vopr Pitan. 2007; 76: 67-73.
58. Kharitonova M, Iezhitsa I, Zheltova A, Ozerov A, Spasov A, Skalny A. Comparative angioprotective effects of magnesium compounds. J Trace Elem Med Biol. 2015; 29: 227-34. doi: 10.1016/j.jtemb.2014.06.026.
59. Maier JA, Malpuech-Brugère C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta. 2004; 1689: 13-21.
60. Bunte MC, Patnaik MM, Pritzker MR, Burns LJ. Pulmonary venoocclusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant. 2008; 41: 677-86. doi: 10.1038/sj.bmt.1705990.
61. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003; 41: 7S-14S.
62. Mak IT, Komarov AM, Wagner TL, Stafford RE, Dickens BF, Weglicki WB. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am J Physiol. 1996; 271: C385-90.
63. Carlin Schooley M, Franz KB. Magnesium deficiency during pregnancy in rats increases systolic blood pressure and plasma nitrite. Am J Hypertens. 2002; 15: 1081-6.
64. Yokoyama T, Oono H, Miyamoto A, Ishiguro S, Nishio A. Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. Life Sci. 2003; 72: 1247-57.
65. Nagai N, Fukuhata T, Ito Y. Effect of magnesium deficiency on intracellular ATP levels in human lens epithelial cells. Biol Pharm Bull. 2007; 30: 6-10.
66. Rock E, Astier C, Lab C, Malpuech C, Nowacki W, Gueux E, et al. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes Res. 1995; 8: 237-422.
67. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24: 998-1005.
68. Obata T. Nitric oxide and depolarization induce hydroxyl radical generation. Jpn J Pharmacol. 2002; 88: 1-5.
69. Salvemini D, Doyle TM, Cuzzocrea S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem Soc Trans. 2006; 34: 965-70.
70. Han W, Fu S, Wei N, Xie B, Li W, Yang S, et al. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation. Int J Cardiol. 2008; 130: 165-73. doi: 10.1016/j.ijcard.2008.02.026.
71. Goubern M, Rayssiguier Y, Miroux B, Chapey MF, Ricquier D, Durlach J. Effect of acute magnesium deficiency on the masking and unmasking of the proton channel of the uncoupling protein in rat brown fat. Magnes Res. 1993; 6: 135-43.
72. Turlapaty PD, Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978; 52: 421-3.
73. Altura BM, Altura BT. Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res. 1995; 41: 347-59.
74. Malis CD, Bonventre JV. Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. A model for postischemic and toxic mitochondrial damage. J Biol Chem. 1986; 261: 14201-8.
75. Kristián T, Siesjö BK. Calcium in ischemic cell death. Stroke. 1998; 29: 705-18.
76. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004; 287: C817-C833.
77. Boczkowski J, Lisdero CL, Lanone S, Samb A, Carreras MC, Boveris A, et al. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 1999; 13: 1637-46.
78. Singh IN, Sullivan PG, Hall ED. Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J Neurosci Res. 2007; 85: 2216-23.
79. Rayssiguier Y, Libako P, Nowacki W, Rock E. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation. Magnes Res. 2010; 23: 73-80.
80. Spasov AA. Magnesium in medical practice. Volgograd, "Otrok", 2000, 268. (Russian)
81. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Failure of beta-cell function for compensate variation in insulin sensitivity in hypomagnesemic subjects. Magnes Res. 2009; 22: 151-6.
82. 2+in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res. 2010; 23: 5-18. doi: 10.1684/mrh.2009.0195.
83. Nassir F, Mazur A, Giannoni F, Gueux E, Davidson NO, Rayssiguier Y. Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim Biophys Acta. 1995; 1257: 125-322.
84. King JL, Miller RJ, Blue JP Jr, O'Brien WD Jr, Erdman JW Jr. Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. Nutr Res. 2009; 29: 343-9. doi: 10.1016/j.nutres.2009.05.001.
85. Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr. 2006; 25: 210-5.
86. Chakraborti S, Michael JR, Patra SK. Protein kinase C dependent and independent activation of phospholipase A2 under calcium ionophore (A23187) exposure in rabbit pulmonary arterial smooth muscle cells. FEBS Lett. 1991; 285: 104-7.
87. Murthy M, Rao GH, Robinson P, Reddy S. Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets. Prostaglandins Leukot Essent Fatty Acids. 1995; 53: 31-9.
88. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998; 39: 1529-42.
89. Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem. 2008; 283: 15539-43. doi: 10.1074/jbc.R800001200.
90. Agarwal R, Iezhitsa L, Agarwal P. Pathogenetic role of magnesium deficiency in ophthalmic diseases. Biometals. 2014; 27: 5-18. doi: 10.1007/s10534-013-9684-5
91. Agarwal R, Iezhitsa IN, Agarwal P, Spasov AA. Mechanisms of cataractogenesis in the presence of magnesium deficiency. Magnes Res. 2013; 26: 2-8. http://www.jle.com/e-docs/00/04/86/AC/vers-alt/VersionPDF.pdf doi: 10.1684/mrh.2013.0336
92. Iezhitsa IN, Spasov AA. Potassium magnesium homeostasis: physiology, pathophysiology, clinical consequences of deficiency and pharmacological correction. Usp Fiziol Nauk. 2008; 39: 23-41.
93. Iezhitsa IN. Potassium and magnesium depletions in congestive heart failure-pathophysiology, consequences and replenishment. Clin Calcium. 2005; 15: 123-33.